House of Lords Business
Show full summary

Lord Hunt of Kings Heath to ask His Majesty's Government what cost assessment they have undertaken of the daily dose rationing of liothyronine regardless of clinical need by the (1) NHS Devon, (2) NHS Buckinghamshire, and (3) NHS Hertfordshire, Integrated Care Boards; and what comparative assessment they have made of (a) the NHS England national guidance, and (b) the National Institute for Health and Care Excellence British National Formulary guidance on liothyronine, given the risk of harm to patients and that smaller doses lead to higher costs. 

Question HL5206: tabled on 30 January 2023 and due for answer by 13 February 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask His Majesty's Government what cost assessment they have undertaken of the daily dose rationing of liothyronine regardless of clinical need by the (1) NHS Devon, (2) NHS Buckinghamshire, and (3) NHS Hertfordshire, Integrated Care Boards; and what comparative assessment they have made of (a) the NHS England national guidance, and (b) the National Institute for Health and Care Excellence British National Formulary guidance on liothyronine, given the risk of harm to patients and that smaller doses lead to higher costs.  HL5206
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Thursday 9 February 2023

Member's Registered Interests

There are no interests to show.

Main Member

Lord Hunt of Kings Heath
Labour
Life peer